MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0437
-0.0013 (-2.78%)
At close: 3:58PM EDT
Stock chart is not supported by your current browser
Previous Close0.0450
Open0.0400
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0400 - 0.0477
52 Week Range0.0400 - 0.1100
Volume7,123,539
Avg. Volume5,455,020
Market Cap206.844M
Beta (3Y Monthly)-2.22
PE Ratio (TTM)N/A
EPS (TTM)-0.0140
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire

    Medical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics

    SAN DIEGO, Aug. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that equity research firm Avise Analytics, Ltd. ("Avise Analytics") ranked the Company as one of the Top 5 Companies in the Hemp-Based Cannabidiol (CBD) Market. "It is an honor to once again be recognized as a leader in the cannabis industry and specifically the CBD market," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. Avise Analytics, founded in 2012, is an international provider of high-quality research and offers a comprehensive range of customized equity research outsourcing services, investment, financial and credit research outsourcing solutions.

  • Benzinga

    Everyday CBD: Sun, Sand, And SeaBD

    If you’ve been paying attention to the sunscreen scene of late, you’ve probably seen how tropical destinations like Hawaii and Key West are banning common sunscreen chemicals oxybenzone and octinoxate since they damage delicate marine ecosystems. According to Punjabi, the benefits center around the anti-inflammatory properties of CBD, which can help “almost every skin condition you can think of—from eczema to acne.” Since the skin doesn’t absorb CBD as well as inhaling or ingesting it—which allows it to enter the bloodstream—CBD-based skincare products are a great “gateway” product for consumers new to the hemp industry.

  • Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as Stevie® Award Winners in 2019 International Business Awards®
    PR Newswire

    Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as Stevie® Award Winners in 2019 International Business Awards®

    SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company was named the winner of a Bronze Stevie® Award in the Most Innovative Company of the Year – Up to 100 Employees category in The 16th Annual International Business Awards. "Medical Marijuana, Inc. has been devoted to innovating all aspects of the CBD industry since new management took control in March 2011," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

  • PR Newswire

    Medical Marijuana, Inc. Reports $20.7 Million in Revenue in Q2 2019, Up 30% Year-Over-Year in Financial Results

    SAN DIEGO , Aug. 15, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...

  • GlobeNewswire

    Medical Marijuana, Inc. Announces Second Quarter Filing Date and Schedules Investor Conference Call for August 15, 2019

    Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that the Company will file its second quarter financial and operational results on August 14 and will host an investor conference call at 4:30 PM ET on Thursday, Aug. 15, to discuss earnings for the quarter ending June 30, 2019. Medical Marijuana, Inc. CEO Dr. Stuart Titus and COO Blake Schroeder will provide updates on the financial and operational performance of the Company in the second quarter of 2019, share recent research and development progress, and discuss where the company is headed for the remainder of the year and in the future.

  • Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies
    PR Newswire

    Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies

    SAN DIEGO , Aug. 7, 2019 /PRNewswire/ --  Medical Marijuana, Inc . (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived ...

  • Benzinga

    CBD And Chemotherapy-Induced Peripheral Neuropathy: What Science Tells Us

    A recent study revealed research findings around chemotherapy-induced peripheral neuropathy, or CIPN, and the potential for CBD as a treatment. The study, conducted by Kannalife, a company in the Medical Marijuana Inc (OTC: MJNA) portfolio, and published in the Journal of Molecular Neuroscience, showed that both CBD and the company's proprietary CBD-like molecule, KLS-13019, had protective action on the mitochondrial exchanger known to increase calcium levels — and therefore neuropathic pain — in patients taking the chemotherapy drug paclitaxel. It's actually a greater difference in potency," said Dr. Doug Brenneman, Kannalife's lead scientist.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiaries HempMeds®, HempMeds® Mexico and HempMeds® Brasil Announce July 2019 as the Largest Sales Bookings Month in Company History

    SAN DIEGO , Aug. 6, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products

    SAN DIEGO, Aug. 1, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first publicly traded cannabis company in the United States that launched the world's preeminent cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has entered a strategic partnership with Endocanna Health, Inc., ("Endocanna") a research and development biotechnology company specializing in endocannabinioid DNA testing and personalization. Kannaway® and Endocanna will collaborate on the development and distribution of endocannabinoid DNA test products. Under the terms of the agreement, Endocanna will manufacture its patent-pending Endocannabinoid DNA Test Kits (the "Kits") and license its proprietary DNA technology to Kannaway®.

  • GlobeNewswire

    Medical Marijuana, Inc. Begins Manufacturing Operations Under An Industrial Hemp Processor License

    Medical Marijuana, Inc. (MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has begun manufacturing operations under an industrial hemp processor license. This processor license will allow Medical Marijuana, Inc. to freely store, handle and convert industrial hemp into a marketable form.

  • GlobeNewswire

    Medical Marijuana, Inc. Opens New Production & Warehousing Facility to Expedite International Expansion Efforts

    Medical Marijuana, Inc. (MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today the expansion of its operations with a new production and warehouse facility. The facility has been designed to help the Company increase warehousing, fulfillment and production activities related to the Company’s CBD hemp oil products.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Grows International Leadership Team With Janne Heimonen as Managing Director of European Division

    SAN DIEGO, July 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that that its subsidiary Kannaway® has appointed Janne Heimonen as Managing Director of its burgeoning European Division. Kannaway® currently ships its products to many countries within the EU. The company is working to expand access to CBD and hemp throughout Europe and has grown to a nearly $40 million revenue run rate since its official launch in 2018.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces Updated Branding Strategy and Website to Expand Consumer Reach

    SAN DIEGO, July 11, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a completely redesigned website and the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products. Through its newly designed consumer-driven website, the Company hopes that consumers will find it easier to navigate for access to the products and CBD education that fits their unique lifestyles.

  • PR Newswire

    Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Announce June 2019 as the Largest Sales Bookings Month in Company History

    - Medical Marijuana, Inc. completed the first-ever high-level stability study on a cannabidiol (CBD) hemp oil product - Subsidiary Kannaway® began pre-marketing initiatives in Japan ahead of significant ...

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Industrial Hemp Association Membership

    SAN DIEGO, July 2, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has become a member of the European Industrial Hemp Association (EIHA) and will participate in the organization's operational and legislative activities.

  • PR Newswire

    Medical Marijuana, Inc. Issues Letter to Shareholders

    SAN DIEGO, June 27, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has issued a letter to its shareholders, providing commentary on the Company's recent financial and operational results and upcoming objectives. Overview of the Company's "One Plant | Three Initiatives" approach to capitalize on the growing industrial hemp and CBD industries by being a global house of brands, leader in research and development of cannabinoid-based therapeutics, and worldwide supplier of high-quality CBD raw materials. Commentary on the Company's financial progress and recent financial results, which included record gross sales, increased gross profit, decreases in operating expenses as a percentage of sales, and a non-GAAP financial analysis including adjusted EBITDA for the most recent quarter.

  • PR Newswire

    Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc.'s Cannabinoid Oral Care Products Registered For Use In Clinical Trials Through Australian Healthcare Partner

    NEW YORK , June 26, 2019 /PRNewswire/ -- Medical Marijuana, Inc.  (OTC: MJNA ) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...

  • Dixie Botanicals®, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen
    PR Newswire

    Dixie Botanicals®, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen

    SAN DIEGO, June 21, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Dixie Botanicals® has partnered with Surface Products Corp. to sell a fitness-focused hemp-derived CBD sunscreen for active consumers.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Third Series of Cannabinoid Medicine Courses in São Paulo

    - The company's Brazilian subsidiary is launching its third series of courses to teach doctors about cannabinoids, the endocannabinoid system and potential therapeutic uses of cannabidiol (CBD) in Brazil ...

  • PR Newswire

    Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc. Moves Forward on Oral Healthcare Line With Cannabinoid Product Supply Agreement

    SAN DIEGO , June 13, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC:MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • Medical Marijuana, Inc. Announces Completion of the First-Ever High-Level Stability Study on a CBD Hemp Oil Product
    PR Newswire

    Medical Marijuana, Inc. Announces Completion of the First-Ever High-Level Stability Study on a CBD Hemp Oil Product

    SAN DIEGO, June 12,  2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-XTM). "We're excited to offer consumers and retail partners the transparency and security of knowing that our products are reliable and stable throughout several climatic conditions and through transportation," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. This helps the company ensure to its customers and retailers that the integrity of the product will not be compromised while in transportation or while being stored for future use," said Medical Marijuana, Inc. Vice President of Project Analysis and R&D, Dr. Levan Darjania.

  • ACCESSWIRE

    Medical Marijuana, Inc. joins The Stock Day Podcast to Discuss Major Accomplishments for 2019

    PHOENIX, AZ / ACCESSWIRE / June 10, 2019 / The Stock Day Podcast welcomed Medical Marijuana, Inc. (OTC PINK: MJNA) ("the Company"), a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. President and CEO, Dr. Stuart Titus, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company's recent FDA hearing.

  • Medical Marijuana, Inc. Subsidiary HempMeds® Adds New CBD-Infused Products to Personal Care Line
    PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Adds New CBD-Infused Products to Personal Care Line

    Research firm Jeffries estimates that the CBD beauty category could reach $25 billion globally and will amass 15 percent of the total skin care market within the next decade. "We have a long history of being a pioneer in the CBD industry and want to continue to be recognized as a leader in industry trends with these new products," said HempMeds® President Todd Morrow. HempMeds® Personal Care Line initially launched in April 2019 on International Women's Day and due to the positive response the company received about these products and feedback from customers who were looking for more topical options, HempMeds® made the strategic decision to add a Soothing Body Balm, a revitalized version of HempMeds® Active Relief Roll-On, and an Essential Body Oil.

  • PR Newswire

    Medical Marijuana, Inc. Announces International Coverage at FDA Public Hearing on Cannabis and CBD Products

    SAN DIEGO, June 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Dr. Stuart Titus, the Company's Chief Executive Officer, was featured in several national and international news publications about his speaking engagement at the U.S. Food and Drug Administration (FDA) Hearing on cannabis and cannabidiol (CBD) on Friday, May 31, 2019. Just last year, Medical Marijuana, Inc. saw a year-over-year revenue increase of more than 125% over 2017. Also, the Brightfield Group stated in its 2018 Annual Report that the CBD market is expected to grow by nearly 40 times within the next four years, outpacing the rest of the cannabis market, including Tetrahydrocannabinol (THC) marijuana products, to reach $22 billion by 2022.

  • Marijuana CEO: 'Many of us are cannabinoid deficient'
    Yahoo Finance

    Marijuana CEO: 'Many of us are cannabinoid deficient'

    Medical Marijuana Inc (MJNA) CEO Stuart Titus is optimistic about the effects that cannabis-derived products have on humans.